Utilizing Patient-reported Outcomes in Cancer Clinical Trials
Assessing new anticancer therapeutics in clinical trials is a vital step in evaluating the toxicity and efficacy of treatment...
Category: Journals
Assessing new anticancer therapeutics in clinical trials is a vital step in evaluating the toxicity and efficacy of treatment...
Skin cancer is the most commonly diagnosed cancer in the United States. Every year, about 5 million Americans are...
Multiple myeloma arises in immune cells called plasma cells. It is one of the most commonly diagnosed hematological malignancies...
Norman E. “Ned” Sharpless, MD, who became director of the National Cancer Institute in October 2017, recently unveiled areas...
The concept of body mass index, or BMI, was introduced in the 19th century by the Belgian statistician Adolphe...
Cigarette smoking is linked to 18 different types of cancer. It is the leading preventable cause of cancer in...
The American Association for Cancer Research (AACR) recently appointed Chi Van Dang, MD, PhD, as the new editor-in-chief of...
Prostate cancer is one of the most common cancers diagnosed in the United States. About one-third of men diagnosed...
Several clinical trials are underway in which PARP inhibitors are being tested in breast cancers, mostly triple-negative breast cancers,...
In recent years, the U.S. Food and Drug Administration has approved immune checkpoint inhibitors, a class of immunotherapy, to...